Dendritic cells vaccine(Hospital Clinic of Barcelona)

To study the efficacy of a therapeutic HIV vaccine consisting of autologous myeloid dendritic cells pulsed ex vivo with high doses of inactivated autologous HIV-1, in HIV-1 infected patients in a very early stages of the disease (CD4 > 450 x 10 6 /L).
To analyze the HIV-1 humoral and cellular immune responses induced by this immune-based therapy.